Teva Pharmaceuticals USA is recalling 30,382 patches of Lidocaine Patch 5% (700 mg) because the product failed stability specifications during testing. This prescription medication, used to treat pain, may not maintain its required strength or quality through its shelf life, which could impact its effectiveness. If you have this product, you should contact your healthcare provider or pharmacist for guidance on continued use and how to obtain a replacement.
The failure to meet stability specifications means the medication may not perform as intended over time, potentially leading to inadequate pain relief for patients relying on the patch.
Pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.